Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer

BACKGROUND: Acquired epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance limits the long-term clinical efficacy of tyrosine kinase-targeting drugs. Although most of the mechanisms of acquired EGFR-TKI resistance have been revealed, the mechanism of ~ 15% of cases has not...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Hematol Oncol
Päätekijät: Fu, Yulong, Zhang, Yang, Lei, Zhe, Liu, Ting, Cai, Tingting, Wang, Anqi, Du, Wenwen, Zeng, Yuanyuan, Zhu, Jianjie, Liu, Zeyi, Huang, Jian-an
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720454/
https://ncbi.nlm.nih.gov/pubmed/33287873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-01009-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia